People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...

Men experience and express depression differently, often coping through unhealthy behaviors and resisting treatment due to ...

The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...

A positive response to treatment for pediatric obesity has enduring health benefits into young adulthood, according t ...

People with bipolar disorder face stigma and treatment challenges. Despite these barriers, it's possible to live a full and ...

Chinese actress Zhao Lusi has made her first public appearance following a month-long treatment for depression, capturing ...

A Texas judge revealed that her husband used a bulk of his life savings to help pay for her treatment for clinical depression ...

Artificial Intelligence has proven to positively transform a wide range of sectors. Healthcare is one such sector that has ...

Chloe Ferry is in hospital as she prepares to undergo surgery to reverse her botched cosmetic procedures after revealing she ...

Scientists and legislative activists will meet Tuesday night to discuss the current state of the use of psychedelic substances to treat mental health conditions.

South Africa faces a growing crisis as chronic vascular diseases affect both body and mind. With one-third of adults battling ...